cart

0.00
HPLC testedCOA every batchEU shippingSEPA · secure paymentResearch Use Only
PEPTIQA BIOTECHSermorelin5 mgPurity 98.5% · RUO

Excellent

Rating 4.8 / 5 — early quality score

Peptiqa Reviews

Early quality score — buyers can leave a review after verified purchase.

Sermorelin

5 mg98.5% purityLot #SERMOR-2026-001

SKU of selected dimension: PEP-SERM-5MG

Sermorelin (GRF 1-29) is a laboratory-produced peptide modeled after the first 29 amino acids of the body's natural growth hormone-releasing hormone (GHRH). By acting directly on the pituitary gland, it encourages the natural synthesis and release of human growth hormone (hGH) while maintaining the body's built-in hormonal control systems. Unlike direct HGH administration, Sermorelin relies on physiological feedback mechanisms, helping prevent unnaturally elevated growth hormone levels. Previously marketed as Geref®, it received FDA approval for the diagnosis and treatment of growth hormone deficiency in pediatric patients. Scientific investigations have linked Sermorelin therapy to improvements in lean muscle mass, sleep quality, insulin sensitivity, and overall vitality. Because pituitary feedback remains intact, its safety profile is generally viewed as more favorable than that of exogenous HGH replacement.
€91.50incl. VAT
In Stock (40)

Volume pricing

QuantityUnit priceSavings
1 vial91.50
3 vials (−7%)85.40−7%
5 vials (−12%)80.52−12%
Purchase & earn 75 points!

Ratings & reviews

Log in to rate this product after your order arrives. login

Certificate of Analysis

Lab Verified
View certificate before purchase — transparency guaranteed
Research Profile

Sermorelinscientific profile

Content is for educational and research purposes. Research Use Only.

  • Sermorelin (GRF 1-29) is a laboratory-produced peptide modeled after the first 29 amino acids of the body's natural growth hormone-releasing hormone (GHRH). By acting directly on the pituitary gland, it encourages the natural synthesis and release of human growth hormone (hGH) while maintaining the body's built-in hormonal control systems. Unlike direct HGH administration, Sermorelin relies on physiological feedback mechanisms, helping prevent unnaturally elevated growth hormone levels. Previously marketed as Geref®, it received FDA approval for the diagnosis and treatment of growth hormone deficiency in pediatric patients. Scientific investigations have linked Sermorelin therapy to improvements in lean muscle mass, sleep quality, insulin sensitivity, and overall vitality. Because pituitary feedback remains intact, its safety profile is generally viewed as more favorable than that of exogenous HGH replacement.

More from GH peptidi

This site uses cookies

Accept